Alpha-1 antitrypsin deficiency
Also known as: Alpha-1 proteinase inhibitor deficiency, AAT deficiency, A1AT deficiency, A1ATD
Alpha-1 antitrypsin deficiency is an inherited disorder associated with reduced protection of lung tissue and, in some variants, abnormal protein accumulation in the liver. Clinical expression varies, including emphysema, chronic airflow obstruction, and liver disease; panniculitis is an uncommon manifestation. Specialist respiratory and hepatology care, disease-specific medical management, and family counselling remain central. Chinese-medicine assessment may provide an adjunctive framework for discussing stable symptoms such as fatigue, cough, or sputum, but cannot correct the underlying genetic defect. the cited evidence contains no clinical proof supporting acupuncture or Chinese herbal formulas for this condition. Herbal interventions require extreme caution because liver involvement and supplement-associated hepatic or renal injury may coexist.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Cessation of smoking and avoidance of environmental tobacco smoke is mandatory; engage professional smoking cessation support and minimise exposure to occupational particulates or chemical fumes.
- •Adhere to all respiratory and hepatology specialist consultations, including recommended immunisation schedules, diagnostic monitoring, and referral for family genetic counselling.
- •Implement paced physical activity with structured rest intervals and participate in pulmonary rehabilitation programmes as indicated; never titrate prescribed oxygen flow rates without medical authorisation.
- •Maintain adequate nutrition, discuss alcohol avoidance with the liver team, and bring a comprehensive list of all medicines, supplements, and herbal products to medical reviews.
Cautions & Contraindications
- •Do not self-treat liver disease with herbal products or start a formula during unexplained liver-test deterioration. The supplied CAM toxicity case supports vigilance for hepatic and renal injury, but does not establish that the formulas listed here caused that case or are safe in AAT deficiency.[]
- •Stop non-essential herbal products and arrange prompt medical assessment if jaundice, dark urine, severe nausea or reduced urine output develops. Suspected product-related injury requires documentation of ingredients, timing and concurrent medicines.[]
- •Defer elective adjunctive treatment when fever, progressive breathlessness and inflamed skin lesions occur together. The supplied panniculitis case illustrates serious respiratory compromise and diagnostic uncertainty, not evidence for acupuncture or herbal treatment.[]
When to reassess or seek care again
Before adjunctive care, record baseline breathlessness using a consistent scale, cough and sputum burden, fatigue, activity tolerance and current respiratory and liver management. Review any stable-symptom trial after 2–4 weeks using the same measures and adverse-event checks; discontinue if there is no meaningful benefit. Obtain immediate medical assessment for red flags and earlier respiratory review for worsening exercise tolerance, increased reliever use or changing sputum. Liver-test monitoring and any decision to consider herbs must be directed by the treating medical team; symptomatic improvement does not demonstrate improved AAT biology or organ function.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Clinical, cosmetic and investigational dermatology · 2026
- Biomolecules & biomedicine · 2025
- Cureus · 2025
- BMC cardiovascular disorders · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
